Contract manufacturer Siegfried amps up in China with new plant

Tracy Staton Switzerland-based contract manufacturer Siegfried has decided to join the construction line in China with a Nantong plant expected to start turning out drug products by ...

Amarin Submits sNDA for Vascepa

barbara.lempert Amarin Announces Submission of Supplemental New Drug Application for Novasep as Fourth Vascepa(R) Active Pharmaceutical Ingredient Supplier BEDMINSTER, N.J. and DUBLIN, ...

Industry Voices: Researching ALS through new eyes–Why data science will foster life science breakthroughs

Alok Saboo An innovative new approach, drawing on the disciplines of both medical science and data science, offers the promise of an unprecedented breakthrough in the search for a cure ...

Argos turns to unusual players for $42.5M needed to fund PhIII cancer study

John Carroll With a Phase III cancer immunotherapy study under way, Durham, NC-based Argos Therapeutics today put in place its fifth fundraising, banking $ 42.5 million from a big ...

Fierce welcomes newest publication: FierceDiagnostics

Rebecca Friend Three years ago, the Fierce Life Sciences team launched FierceMedicalDevices to provide more coverage in the medtech space. Now we're expanding yet again with the ...

New UCLA Clinical Trial of MediciNova’s MN-166 in Treating Alcoholism Funded

barbara.lempert National Institute on Alcohol Abuse and Alcoholism Funds New UCLA Clinical Trial of MediciNova’s MN-166 in Treating Alcoholism                  ...

Rigel shares slide after another drug flops in PhII asthma study

John Carroll Shares of Rigel Pharmaceuticals took a dive this morning, dropping 17% after the South San Francisco-based biotech announced that it is burying a program for allergic asthma ...

Lonza will cut 200 at Massachusetts plant by end of year

Eric Palmer Lonza last month said it was going to phase out work at its troubled biologics plant in Hopkinton, MA, eventually cutting about 250 jobs. At the time it didn't put a ...

PharmaHelps webinar reviews effects of increased quality measurements

mia.burns By Mia Burns A two-part webinar from the PharmaHelps Network  focuses on ways that providers, payers, and the pharma industry can work together to improve the patient experience ...

Ceptaris wins FDA OK for lymphoma gel, clears path to $250M Actelion buyout

John Carroll Malvern, PA-based Ceptaris Therapeutics nailed a delayed FDA approval for Valchlor, a drug designed for the most common form of cutaneous T-cell lymphoma. And the OK clears ...

PharmaHelps webinar examines increased quality measurements in healthcare reform era

mia.burns bryantBROWN Healthcare partner Bob Brown Participates in the PharmaHelps™ Webinar to Examine the Impact of Increased Quality Measurements in the Era of Healthcare Reform Medical ...

Zafgen’s obesity drug attracts a high-profile spotlight

John Carroll Reuters did an in-depth feature on Zafgen's promising obesity therapy beloranib. The drug works by blocking the methionine aminopeptidase 2, or MetAP2, enzyme–which ...
Page 3 of 3812345...102030...Last »
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS